The FDA has cleared Elecsys pTau181, the first blood test for use in primary care to help rule out Alzheimer’s disease in ...

Measuring blood flow in the brain is critical for responding to a range of neurological problems, including stroke, traumatic brain injury (TBI) and vascular dementia.

Scientists at CSIRO, Australia's national science agency, have identified simpler and less invasive methods to improve Alzheimer's disease diagnosis, potentially making it easier for patients to ...

A second blood test has been been approved by the US Food and Drug Administration to assist in diagnosing Alzheimer’s disease ...